AACR logo

More articles from Protein-protein Interaction: Poster Presentations - Proffered Abstracts

Abstract LB-C02: In vitro on-target and selectivity profiling of small-molecule inhibitors of the Myc/Max heterodimeric complex
SANG-KYU KIM, RICHARD C FOITZIK, SONGHUI LI, ANDREW VINSON, ALEX SHMAYLOV, KAREN JARVIS, SUSAN JAMES, SCOTT R WALKER, MARK YORK, BENJAMIN CAO, SUSAN K NILSSON, RICKY W JOHNSTONE

Molecular Cancer Therapeutics Dec 2019, 18 (12 Supplement) LB-C02; DOI: 10.1158/1535-7163.TARG-19-LB-C02
Abstract LB-B17: Characterization of small molecule inhibitors of the Nrf2-Keap1 interaction using MicroScale Thermophoresis
Julie M. Rainard, Angus J. Morrison, Andrew D. Pannifer, Philip S. Jones, Richard J. Mead, Stuart P. McElroy

Molecular Cancer Therapeutics Jan 2018, 17 (1 Supplement) LB-B17; DOI: 10.1158/1535-7163.TARG-17-LB-B17
Abstract B155: The E3 ubiquitin protein ligase MDM2 dictates all-trans retinoic acid induced osteoblastic differentiation of osteosarcoma cells by modulating the degradation of RARα
Meidan Ying, Qian Zhou, Xuejing Shao, Ji Cao, Hong Zhu, Bo Yang, Qiaojun He

Molecular Cancer Therapeutics Dec 2015, 14 (12 Supplement 2) B155; DOI: 10.1158/1535-7163.TARG-15-B155
Abstract C126: Molecular profiling of the HES transcription factor-TLE co-repressor protein-protein interaction site.
Jon R. Roffey, Tim Hammonds, Tony Raynham, Christian Dillon, Cali Hyde, Laurence Pearl, David Ish-Horowicz

Molecular Cancer Therapeutics Nov 2011, 10 (11 Supplement) C126; DOI: 10.1158/1535-7163.TARG-11-C126
Abstract C127: Crystal structure of the SIX1/EYA transcriptional complex reveals ways to inhibit SIX1-mediated breast tumorigenesis/metastasis.
Aaron Patrick, Joshua Cabrera, Rui Zhao, Heide Ford

Molecular Cancer Therapeutics Nov 2011, 10 (11 Supplement) C127; DOI: 10.1158/1535-7163.TARG-11-C127
Abstract C124: Development of novel FAK inhibitors targeting the FAK-VEGFR3 protein-protein interaction site.
Priyanka A. Agharkar, Manivannan Ethirajan, Jianqun Liao, Michael Yemma, Andrew Magis, William Cance, Ravindra Pandey, Elena Kurenova

Molecular Cancer Therapeutics Nov 2011, 10 (11 Supplement) C124; DOI: 10.1158/1535-7163.TARG-11-C124
Abstract C128: Small-molecule antagonists of MDM2 and MDMX.
Thelma Thompson, Bradford Graves, Mingxuan Xia, Cheryl Janson, Christine Lukacs, Dayanand Deo, Kuo-Sen Huang, Christian Tovar, Allen Lovey, Jutta Wanner, Lyubomir T. Vassilev

Molecular Cancer Therapeutics Nov 2011, 10 (11 Supplement) C128; DOI: 10.1158/1535-7163.TARG-11-C128
Abstract C211: Demonstration of the efficacy of compound CFAK-C4, Targeting FAK-VEGFR-3 protein-protein interaction in animal models of gastric cancer.
Elena Kurenova, Sartaj Sanghera, Jian Liao, Michael Yemma, William Cance

Molecular Cancer Therapeutics Nov 2013, 12 (11 Supplement) C211; DOI: 10.1158/1535-7163.TARG-13-C211
Abstract C212: Discovery of high affinity cyclic peptidomimetics binding Mcl-1 and Ras.
Kristopher Josephson, Zhong Ma, Zhaolin Wang, Yili Sun, Sylvia Tobe, Sarah Perlmutter, Rohit Vyasamneni, Ping Ye, Nicolas Boyer, Micelle Arata, Kelli Pattavina, Kathleen Seyb, Hong Zheng, Imelda Sollomoni, Ezekiel Nims, Emily de Koning, Alonso Ricardo, Douglas Treco

Molecular Cancer Therapeutics Nov 2013, 12 (11 Supplement) C212; DOI: 10.1158/1535-7163.TARG-13-C212
Abstract C210: Atypical chemokine receptor 3/CXCR7 and EGFR interact to control breast cancer growth.
Nicole Salazar, Daniel Muñoz, Bal L. Lokeshwar

Molecular Cancer Therapeutics Nov 2013, 12 (11 Supplement) C210; DOI: 10.1158/1535-7163.TARG-13-C210

Main menu

User menu

Search

More articles from Protein-protein Interaction: Poster Presentations - Proffered Abstracts

Pages

Articles

Info for

About MCT